Decline of chaperone-mediated autophagy in aging impairs macrophage clearance of senescent cells

The reduction in CMA activity compromises the cellular recycling of damaged proteins, a process essential for immune clearance. This impairment contributes to the buildup of dysfunctional cells that are linked to tissue degeneration and chronic inflammation. Nature described the mechanistic link between CMA loss and the slowdown of macrophage‑driven clearance, while Nautilus explained why zombie cells accumulate as the recycling pathway wanes.

Medical Xpress reported the discovery of the age‑related CMA decline, and Drug Target Review suggested that restoring CMA could rejuvenate macrophage function. Bioengineer.org highlighted the pathway as a central driver of aging‑related disease, noting that CMA governs selective protein degradation across multiple tissue types and positioning it as a potential therapeutic target. The proposed CMA restoration remains at the research stage; coverage does not detail any clinical trials or approved interventions, leaving the translational path uncertain.

Future studies will need to assess whether pharmacological activation of CMA can safely enhance macrophage clearance without disrupting normal protein turnover.